Insulin resistance and diabetes are related but distinct conditions. Insulin resistance is a state where your cells stop responding efficiently to insulin, forcing your pancreas to produce more of it to keep blood sugar in check. Diabetes is the disease that develops when your pancreas can no longer compensate for that resistance and blood sugar rises to damaging levels. Insulin resistance typically precedes a type 2 diabetes diagnosis by 10 to 15 years, which means there’s a long window where the problem is building but hasn’t yet crossed into diabetes.
How Insulin Resistance Works in the Body
Insulin is the hormone that tells your cells to absorb glucose from the bloodstream. When everything works normally, insulin binds to receptors on your muscle, fat, and liver cells, triggering a chain of internal signals that open the door for glucose to enter. In insulin resistance, that signaling chain is disrupted. The cells physically have enough insulin receptors, and they produce enough of the internal relay proteins. The problem is that those relay proteins don’t activate properly when insulin arrives, so the “open the door” message gets muffled.
Your pancreas senses that blood sugar isn’t dropping the way it should, so it pumps out more insulin. For years, this works. You walk around with higher-than-normal insulin levels but relatively normal blood sugar, and standard tests may not flag anything unusual. This compensatory phase is why insulin resistance can hide for so long.
When Insulin Resistance Becomes Diabetes
The transition from insulin resistance to type 2 diabetes happens when the insulin-producing beta cells in your pancreas begin to fail. Overworking for years takes a toll. At first, blood sugar rises only after meals, because that’s when glucose demand on your system spikes. Eventually, fasting blood sugar climbs too.
By the time someone’s blood sugar is in the upper range of prediabetes (a two-hour post-meal reading of 180 to 199 mg/dL), they’ve already lost roughly 70% to 80% of their beta cell function. By the time type 2 diabetes is formally diagnosed, more than 80% of that function is gone. This is why diabetes is harder to reverse than insulin resistance: the cellular damage is much further along. It also explains why some people with prediabetes already show early signs of diabetic complications like retinopathy, even before they technically have diabetes.
How the Numbers Differ
The diagnostic cutoffs for prediabetes and diabetes are based on blood sugar and A1C (a measure of average blood sugar over two to three months):
- Normal: A1C below 5.7%, fasting glucose 99 mg/dL or below
- Prediabetes: A1C 5.7% to 6.4%, fasting glucose 100 to 125 mg/dL
- Diabetes: A1C 6.5% or above, fasting glucose 126 mg/dL or above
Insulin resistance itself doesn’t have an official diagnostic threshold on standard blood panels. Doctors sometimes use a calculation called HOMA-IR, which combines your fasting insulin and fasting glucose levels. A HOMA-IR score of roughly 1.9 or above suggests insulin resistance, with slightly different cutoffs for men (1.7) and women (2.0). Another practical marker is your triglyceride-to-HDL cholesterol ratio: a value of 3 or higher correlates strongly with insulin resistance, even when blood sugar still looks normal.
The key distinction: you can be insulin resistant with perfectly normal glucose readings. Diabetes, by definition, means glucose has crossed specific thresholds.
Signs You Can See and Feel
Insulin resistance often has no obvious symptoms in its early stages, which is part of what makes it tricky. But there are physical clues that show up before blood sugar ever rises high enough to qualify as diabetes.
Acanthosis nigricans is one of the most recognizable. These are dark, velvety patches of skin that appear on the neck, armpits, knuckles, or groin. Skin tags, especially clusters of small, soft growths in skin folds, are another common sign. In women, insulin resistance can drive excess androgen production, leading to acne, thinning hair on the scalp, or increased facial and body hair. These skin and hair changes reflect the elevated insulin levels circulating in your body, not high blood sugar, so they can appear years before any diabetes diagnosis.
Diabetes, by contrast, brings symptoms tied to high blood sugar itself: increased thirst, frequent urination, blurred vision, slow-healing wounds, and fatigue. Many people with type 2 diabetes also have the skin signs of insulin resistance, since the resistance doesn’t go away once diabetes develops.
Who Should Be Screened
The American Diabetes Association recommends that all adults begin screening at age 35. If you’re overweight or obese (a BMI of 25 or above, or 23 or above for Asian American individuals), screening should start earlier if you also have at least one additional risk factor. Those risk factors include having a first-degree relative with diabetes, a history of cardiovascular disease, high blood pressure, low HDL cholesterol, high triglycerides, polycystic ovary syndrome, physical inactivity, or belonging to a higher-risk racial or ethnic group (African American, Latino, Native American, Asian American, or Pacific Islander).
Waist circumference matters independently of BMI. A waist measurement over 35 inches for women or over 40 inches for men is associated with metabolic syndrome, a cluster of conditions that includes insulin resistance.
How Treatment Differs
The treatment approach for insulin resistance focuses almost entirely on lifestyle changes: regular physical activity, weight loss, and dietary shifts that reduce refined carbohydrates and added sugars. Exercise directly improves how your cells respond to insulin, sometimes within days. Losing even a modest amount of weight, around 5% to 7% of body weight, significantly reduces the risk of progressing to diabetes.
Medication enters the picture when lifestyle changes aren’t enough. For people with prediabetes, metformin is the only drug currently recommended for prevention. It’s typically started at a lower dose and increased gradually to minimize digestive side effects like diarrhea. In large prevention trials, metformin reduced the risk of developing diabetes by about 31%, though lifestyle changes alone performed even better.
Once diabetes is diagnosed, the treatment landscape expands considerably. Metformin remains the first-line medication, but many people eventually need additional drugs or insulin injections as beta cell function continues to decline. The goals also shift: in insulin resistance, you’re trying to prevent damage. In diabetes, you’re managing damage that’s already underway, monitoring for complications in your eyes, kidneys, nerves, and cardiovascular system.
The Reversibility Gap
This is perhaps the most important practical difference. Insulin resistance is highly reversible. Because your beta cells are still functional during this phase, restoring insulin sensitivity through exercise, weight loss, or medication can bring your metabolic health back to normal. The 10-to-15-year window before diabetes develops is a genuine opportunity.
Type 2 diabetes can sometimes be put into remission, particularly through significant weight loss early after diagnosis, but it becomes progressively harder as more beta cell function is lost. The disease tends to be managed rather than cured. That distinction, reversible versus manageable, is the core reason identifying insulin resistance early matters so much.